The global Medical Grade Chitosan market size was valued at USD 35 million in 2022 and is forecast to a readjusted size of USD 58 million by 2029 with a CAGR of 7.5% during review period.
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
This report is a detailed and comprehensive analysis for global Medical Grade Chitosan market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Medical Grade Chitosan market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Kg), 2018-2029
Global Medical Grade Chitosan market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Kg), 2018-2029
Global Medical Grade Chitosan market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Kg), 2018-2029
Global Medical Grade Chitosan market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Grade Chitosan
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Grade Chitosan market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Animal Origin Chitosan
Plant Based Chitosan
Wound Care
Healthcare Products
Antibacterial Products
Others
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths
- High biocompatibility and biodegradability make medical grade chitosan suitable for various biomedical applications, including wound healing and drug delivery.
- Growing demand for natural and sustainable materials in the healthcare sector enhances the market appeal of medical grade chitosan.
Weaknesses
- Limited awareness and knowledge among healthcare professionals regarding the benefits and applications of medical grade chitosan may hinder its adoption.
- High production costs associated with extracting and processing chitosan can impact market competitiveness against synthetic alternatives.
Opportunities
- Increasing research and development activities in regenerative medicine and tissue engineering present significant growth opportunities for medical grade chitosan.
- Expanding applications in pharmaceuticals, nutraceuticals, and cosmetics can drive market diversification and revenue growth.
Threats
- Stringent regulatory requirements and quality standards in the medical sector may pose challenges for manufacturers seeking market entry.
- The emergence of alternative biomaterials may reduce the market share of medical grade chitosan in certain applications.
Political
- Favorable government policies promoting biodegradable and sustainable materials can drive market growth.
- Trade regulations and tariffs on raw material imports may impact the supply chain and cost structure.
Economic
- Rising healthcare expenditure in emerging markets boosts demand for advanced biomaterials like medical grade chitosan.
- Fluctuations in the cost of raw materials (shrimp, crab shells) can influence product pricing and profitability.
Social
- Increasing consumer preference for eco-friendly and biocompatible products enhances the appeal of medical grade chitosan.
- Growing awareness about chronic disease management fosters demand for wound care and drug delivery applications.
Technological
- Advancements in extraction and processing technologies improve product quality and production efficiency.
- Innovations in nanotechnology open new avenues for medical grade chitosan in targeted drug delivery and tissue engineering.
Environmental
- Rising concerns over plastic waste drive demand for biodegradable alternatives like medical grade chitosan.
- Seasonal variations and environmental changes affecting marine biodiversity can disrupt the raw material supply chain.
Legal
- Stringent regulatory frameworks for medical-grade biomaterials require manufacturers to meet high-quality standards.
- Intellectual property issues surrounding patented processes and formulations may create legal barriers for new entrants.
Suppliers
- Suppliers of chitin (derived from crustacean shells) provide the primary raw material for producing medical grade chitosan.
- Chemical manufacturers supply necessary reagents and processing equipment for chitosan extraction and purification.
Inputs
- Raw chitin sourced from sustainable fisheries serves as the fundamental input for medical grade chitosan production.
- Advanced processing technologies and quality control measures are essential inputs to ensure product compliance with medical standards.
Process
- Chitin is deacetylated through a chemical or enzymatic process to produce chitosan suitable for medical applications.
- The chitosan is then purified, characterized, and formulated for specific medical uses such as wound dressings and drug delivery systems.
Outputs
- Medical grade chitosan products are created for various applications, including wound care, drug delivery, and tissue engineering.
- Value-added products, such as chitosan-based gels and films, are developed for specific therapeutic purposes.
Customers
- Healthcare providers, including hospitals and clinics, represent a key customer segment for medical grade chitosan products.
- Pharmaceutical and biotechnology companies utilize medical grade chitosan for developing innovative drug delivery systems and therapeutics.
Threat of New Entrants
- High capital investment and specialized knowledge required for the production and processing of medical grade chitosan create barriers to entry.
- Regulatory approval and quality control standards in the healthcare sector may discourage new entrants from entering the market.
Bargaining Power of Suppliers
- Limited suppliers of chitin, the key raw material, give these suppliers higher bargaining power in pricing and availability.
- Dependence on sustainable harvesting practices for chitin increases supplier influence on raw material costs and consistency.
Bargaining Power of Buyers
- Healthcare providers and pharmaceutical companies with large purchasing power can negotiate lower prices for medical grade chitosan products.
- Availability of alternative biomaterials for medical applications allows buyers to exert some bargaining power over manufacturers.
Threat of Substitutes
- The availability of other biodegradable and biocompatible materials like collagen and alginate presents a threat of substitution.
- Emerging synthetic materials with lower costs and similar properties could challenge the dominance of medical grade chitosan.
Industry Rivalry
- The market for medical grade chitosan is characterized by moderate competition among a few established players with strong brand recognition.
- Price sensitivity and technological advancements in production processes increase competition in the market, driving companies to innovate.
Raw Material Sources
- Chitin, the primary raw material for medical grade chitosan, is predominantly derived from crustacean shells such as shrimp and crab.
- Sustainable sourcing practices and seasonal variations in marine biodiversity significantly impact the availability and cost of raw materials.
Supply Chain
- Raw material procurement involves partnerships with fisheries, aquaculture facilities, and marine waste processing units to ensure consistent supply.
- Transportation, storage, and initial processing of chitin require specialized infrastructure to maintain quality and prevent contamination.
Processing Technology Providers
- Providers of advanced deacetylation and purification technologies play a critical role in ensuring high-quality chitosan production.
- Suppliers of chemical reagents and bioprocessing equipment influence efficiency and scalability in the production process.
Manufacturing and Processing
- The production process involves converting chitin into chitosan through deacetylation, followed by purification and quality testing to meet medical-grade standards.
- Manufacturers invest in advanced technologies and scalable processes to enhance product consistency and cater to growing demand across medical applications.
Value Addition
- Medical grade chitosan is formulated into specialized products such as wound care dressings, drug delivery systems, and scaffolds for tissue engineering.
- Research and development activities focus on creating innovative applications, including nanostructured chitosan for targeted therapies.
Distribution
- Processed medical grade chitosan is supplied to pharmaceutical, biotechnology, and medical device companies through distributors or direct partnerships.
- Distribution networks prioritize compliance with regulatory standards, ensuring product integrity during transportation and storage.
End-Product Development
- Medical grade chitosan is utilized to develop end-products like wound dressings, hemostatic agents, and drug delivery systems tailored for healthcare applications.
- Innovations in formulations, such as gels, films, and nanoparticles, enhance the functionality and versatility of chitosan-based products.
Distribution to End-Users
- Products are distributed to hospitals, clinics, and pharmaceutical companies through well-established supply chains, ensuring regulatory compliance and timely delivery.
- Direct sales to healthcare providers and collaborations with biotechnology firms facilitate market penetration and product adoption.
Consumer Applications
- Patients benefit from medical-grade chitosan products for wound management, controlled drug delivery, and regenerative medicine therapies.
- Growing consumer preference for biocompatible and eco-friendly medical products drives the adoption of chitosan-based solutions.
Chapter 1, to describe Medical Grade Chitosan product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Grade Chitosan, with price, sales, revenue and global market share of Medical Grade Chitosan from 2018 to 2023.
Chapter 3, the Medical Grade Chitosan competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Grade Chitosan breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Grade Chitosan market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Grade Chitosan.
Chapter 14 and 15, to describe Medical Grade Chitosan sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Medical Grade Chitosan
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medical Grade Chitosan Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Animal Origin Chitosan
1.3.3 Plant Based Chitosan
1.4 Market Analysis by Application
1.4.1 Overview: Global Medical Grade Chitosan Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Wound Care
1.4.3 Healthcare Products
1.4.4 Antibacterial Products
1.4.5 Others
1.5 Global Medical Grade Chitosan Market Size & Forecast
1.5.1 Global Medical Grade Chitosan Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Medical Grade Chitosan Sales Quantity (2018-2029)
1.5.3 Global Medical Grade Chitosan Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Primex
2.1.1 Primex Details
2.1.2 Primex Major Business
2.1.3 Primex Medical Grade Chitosan Product and Services
2.1.4 Primex Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Primex Recent Developments/Updates
2.2 KitoZyme
2.2.1 KitoZyme Details
2.2.2 KitoZyme Major Business
2.2.3 KitoZyme Medical Grade Chitosan Product and Services
2.2.4 KitoZyme Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 KitoZyme Recent Developments/Updates
2.3 BIO21
2.3.1 BIO21 Details
2.3.2 BIO21 Major Business
2.3.3 BIO21 Medical Grade Chitosan Product and Services
2.3.4 BIO21 Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BIO21 Recent Developments/Updates
2.4 YSK
2.4.1 YSK Details
2.4.2 YSK Major Business
2.4.3 YSK Medical Grade Chitosan Product and Services
2.4.4 YSK Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 YSK Recent Developments/Updates
2.5 Vietnam Food
2.5.1 Vietnam Food Details
2.5.2 Vietnam Food Major Business
2.5.3 Vietnam Food Medical Grade Chitosan Product and Services
2.5.4 Vietnam Food Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Vietnam Food Recent Developments/Updates
2.6 NovaMatrix
2.6.1 NovaMatrix Details
2.6.2 NovaMatrix Major Business
2.6.3 NovaMatrix Medical Grade Chitosan Product and Services
2.6.4 NovaMatrix Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 NovaMatrix Recent Developments/Updates
2.7 KIMICA
2.7.1 KIMICA Details
2.7.2 KIMICA Major Business
2.7.3 KIMICA Medical Grade Chitosan Product and Services
2.7.4 KIMICA Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 KIMICA Recent Developments/Updates
2.8 Ningbo Zhenhai Haixin Biological
2.8.1 Ningbo Zhenhai Haixin Biological Details
2.8.2 Ningbo Zhenhai Haixin Biological Major Business
2.8.3 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Product and Services
2.8.4 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ningbo Zhenhai Haixin Biological Recent Developments/Updates
2.9 Golden-Shell Pharmaceutical
2.9.1 Golden-Shell Pharmaceutical Details
2.9.2 Golden-Shell Pharmaceutical Major Business
2.9.3 Golden-Shell Pharmaceutical Medical Grade Chitosan Product and Services
2.9.4 Golden-Shell Pharmaceutical Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Golden-Shell Pharmaceutical Recent Developments/Updates
2.10 Zhejiang Fengrun Biotech
2.10.1 Zhejiang Fengrun Biotech Details
2.10.2 Zhejiang Fengrun Biotech Major Business
2.10.3 Zhejiang Fengrun Biotech Medical Grade Chitosan Product and Services
2.10.4 Zhejiang Fengrun Biotech Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Zhejiang Fengrun Biotech Recent Developments/Updates
2.11 Jiangsu Shuanglin
2.11.1 Jiangsu Shuanglin Details
2.11.2 Jiangsu Shuanglin Major Business
2.11.3 Jiangsu Shuanglin Medical Grade Chitosan Product and Services
2.11.4 Jiangsu Shuanglin Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Jiangsu Shuanglin Recent Developments/Updates
2.12 Jiangsu Aoxin Biotechnology
2.12.1 Jiangsu Aoxin Biotechnology Details
2.12.2 Jiangsu Aoxin Biotechnology Major Business
2.12.3 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Product and Services
2.12.4 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Jiangsu Aoxin Biotechnology Recent Developments/Updates
2.13 Qingdao Yunzhou Biochemistry
2.13.1 Qingdao Yunzhou Biochemistry Details
2.13.2 Qingdao Yunzhou Biochemistry Major Business
2.13.3 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Product and Services
2.13.4 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Qingdao Yunzhou Biochemistry Recent Developments/Updates
3 Competitive Environment: Medical Grade Chitosan by Manufacturer
3.1 Global Medical Grade Chitosan Sales Quantity by Manufacturer (2018-2023)
3.2 Global Medical Grade Chitosan Revenue by Manufacturer (2018-2023)
3.3 Global Medical Grade Chitosan Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Medical Grade Chitosan by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Medical Grade Chitosan Manufacturer Market Share in 2022
3.4.2 Top 6 Medical Grade Chitosan Manufacturer Market Share in 2022
3.5 Medical Grade Chitosan Market: Overall Company Footprint Analysis
3.5.1 Medical Grade Chitosan Market: Region Footprint
3.5.2 Medical Grade Chitosan Market: Company Product Type Footprint
3.5.3 Medical Grade Chitosan Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Medical Grade Chitosan Market Size by Region
4.1.1 Global Medical Grade Chitosan Sales Quantity by Region (2018-2029)
4.1.2 Global Medical Grade Chitosan Consumption Value by Region (2018-2029)
4.1.3 Global Medical Grade Chitosan Average Price by Region (2018-2029)
4.2 North America Medical Grade Chitosan Consumption Value (2018-2029)
4.3 Europe Medical Grade Chitosan Consumption Value (2018-2029)
4.4 Asia-Pacific Medical Grade Chitosan Consumption Value (2018-2029)
4.5 South America Medical Grade Chitosan Consumption Value (2018-2029)
4.6 Middle East and Africa Medical Grade Chitosan Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Medical Grade Chitosan Sales Quantity by Type (2018-2029)
5.2 Global Medical Grade Chitosan Consumption Value by Type (2018-2029)
5.3 Global Medical Grade Chitosan Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Medical Grade Chitosan Sales Quantity by Application (2018-2029)
6.2 Global Medical Grade Chitosan Consumption Value by Application (2018-2029)
6.3 Global Medical Grade Chitosan Average Price by Application (2018-2029)
7 North America
7.1 North America Medical Grade Chitosan Sales Quantity by Type (2018-2029)
7.2 North America Medical Grade Chitosan Sales Quantity by Application (2018-2029)
7.3 North America Medical Grade Chitosan Market Size by Country
7.3.1 North America Medical Grade Chitosan Sales Quantity by Country (2018-2029)
7.3.2 North America Medical Grade Chitosan Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Medical Grade Chitosan Sales Quantity by Type (2018-2029)
8.2 Europe Medical Grade Chitosan Sales Quantity by Application (2018-2029)
8.3 Europe Medical Grade Chitosan Market Size by Country
8.3.1 Europe Medical Grade Chitosan Sales Quantity by Country (2018-2029)
8.3.2 Europe Medical Grade Chitosan Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Medical Grade Chitosan Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Medical Grade Chitosan Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Medical Grade Chitosan Market Size by Region
9.3.1 Asia-Pacific Medical Grade Chitosan Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Medical Grade Chitosan Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Medical Grade Chitosan Sales Quantity by Type (2018-2029)
10.2 South America Medical Grade Chitosan Sales Quantity by Application (2018-2029)
10.3 South America Medical Grade Chitosan Market Size by Country
10.3.1 South America Medical Grade Chitosan Sales Quantity by Country (2018-2029)
10.3.2 South America Medical Grade Chitosan Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Medical Grade Chitosan Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Medical Grade Chitosan Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Medical Grade Chitosan Market Size by Country
11.3.1 Middle East & Africa Medical Grade Chitosan Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Medical Grade Chitosan Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Medical Grade Chitosan Market Drivers
12.2 Medical Grade Chitosan Market Restraints
12.3 Medical Grade Chitosan Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Medical Grade Chitosan and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Grade Chitosan
13.3 Medical Grade Chitosan Production Process
13.4 Medical Grade Chitosan Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Grade Chitosan Typical Distributors
14.3 Medical Grade Chitosan Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Medical Grade Chitosan Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Medical Grade Chitosan Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Primex Basic Information, Manufacturing Base and Competitors
Table 4. Primex Major Business
Table 5. Primex Medical Grade Chitosan Product and Services
Table 6. Primex Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Primex Recent Developments/Updates
Table 8. KitoZyme Basic Information, Manufacturing Base and Competitors
Table 9. KitoZyme Major Business
Table 10. KitoZyme Medical Grade Chitosan Product and Services
Table 11. KitoZyme Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. KitoZyme Recent Developments/Updates
Table 13. BIO21 Basic Information, Manufacturing Base and Competitors
Table 14. BIO21 Major Business
Table 15. BIO21 Medical Grade Chitosan Product and Services
Table 16. BIO21 Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BIO21 Recent Developments/Updates
Table 18. YSK Basic Information, Manufacturing Base and Competitors
Table 19. YSK Major Business
Table 20. YSK Medical Grade Chitosan Product and Services
Table 21. YSK Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. YSK Recent Developments/Updates
Table 23. Vietnam Food Basic Information, Manufacturing Base and Competitors
Table 24. Vietnam Food Major Business
Table 25. Vietnam Food Medical Grade Chitosan Product and Services
Table 26. Vietnam Food Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Vietnam Food Recent Developments/Updates
Table 28. NovaMatrix Basic Information, Manufacturing Base and Competitors
Table 29. NovaMatrix Major Business
Table 30. NovaMatrix Medical Grade Chitosan Product and Services
Table 31. NovaMatrix Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. NovaMatrix Recent Developments/Updates
Table 33. KIMICA Basic Information, Manufacturing Base and Competitors
Table 34. KIMICA Major Business
Table 35. KIMICA Medical Grade Chitosan Product and Services
Table 36. KIMICA Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. KIMICA Recent Developments/Updates
Table 38. Ningbo Zhenhai Haixin Biological Basic Information, Manufacturing Base and Competitors
Table 39. Ningbo Zhenhai Haixin Biological Major Business
Table 40. Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Product and Services
Table 41. Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Ningbo Zhenhai Haixin Biological Recent Developments/Updates
Table 43. Golden-Shell Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Golden-Shell Pharmaceutical Major Business
Table 45. Golden-Shell Pharmaceutical Medical Grade Chitosan Product and Services
Table 46. Golden-Shell Pharmaceutical Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Golden-Shell Pharmaceutical Recent Developments/Updates
Table 48. Zhejiang Fengrun Biotech Basic Information, Manufacturing Base and Competitors
Table 49. Zhejiang Fengrun Biotech Major Business
Table 50. Zhejiang Fengrun Biotech Medical Grade Chitosan Product and Services
Table 51. Zhejiang Fengrun Biotech Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Zhejiang Fengrun Biotech Recent Developments/Updates
Table 53. Jiangsu Shuanglin Basic Information, Manufacturing Base and Competitors
Table 54. Jiangsu Shuanglin Major Business
Table 55. Jiangsu Shuanglin Medical Grade Chitosan Product and Services
Table 56. Jiangsu Shuanglin Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Jiangsu Shuanglin Recent Developments/Updates
Table 58. Jiangsu Aoxin Biotechnology Basic Information, Manufacturing Base and Competitors
Table 59. Jiangsu Aoxin Biotechnology Major Business
Table 60. Jiangsu Aoxin Biotechnology Medical Grade Chitosan Product and Services
Table 61. Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Jiangsu Aoxin Biotechnology Recent Developments/Updates
Table 63. Qingdao Yunzhou Biochemistry Basic Information, Manufacturing Base and Competitors
Table 64. Qingdao Yunzhou Biochemistry Major Business
Table 65. Qingdao Yunzhou Biochemistry Medical Grade Chitosan Product and Services
Table 66. Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales Quantity (Ton), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Qingdao Yunzhou Biochemistry Recent Developments/Updates
Table 68. Global Medical Grade Chitosan Sales Quantity by Manufacturer (2018-2023) & (Ton)
Table 69. Global Medical Grade Chitosan Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Medical Grade Chitosan Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 71. Market Position of Manufacturers in Medical Grade Chitosan, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Medical Grade Chitosan Production Site of Key Manufacturer
Table 73. Medical Grade Chitosan Market: Company Product Type Footprint
Table 74. Medical Grade Chitosan Market: Company Product Application Footprint
Table 75. Medical Grade Chitosan New Market Entrants and Barriers to Market Entry
Table 76. Medical Grade Chitosan Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Medical Grade Chitosan Sales Quantity by Region (2018-2023) & (Ton)
Table 78. Global Medical Grade Chitosan Sales Quantity by Region (2024-2029) & (Ton)
Table 79. Global Medical Grade Chitosan Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Medical Grade Chitosan Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Medical Grade Chitosan Average Price by Region (2018-2023) & (US$/Kg)
Table 82. Global Medical Grade Chitosan Average Price by Region (2024-2029) & (US$/Kg)
Table 83. Global Medical Grade Chitosan Sales Quantity by Type (2018-2023) & (Ton)
Table 84. Global Medical Grade Chitosan Sales Quantity by Type (2024-2029) & (Ton)
Table 85. Global Medical Grade Chitosan Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Medical Grade Chitosan Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Medical Grade Chitosan Average Price by Type (2018-2023) & (US$/Kg)
Table 88. Global Medical Grade Chitosan Average Price by Type (2024-2029) & (US$/Kg)
Table 89. Global Medical Grade Chitosan Sales Quantity by Application (2018-2023) & (Ton)
Table 90. Global Medical Grade Chitosan Sales Quantity by Application (2024-2029) & (Ton)
Table 91. Global Medical Grade Chitosan Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Medical Grade Chitosan Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Medical Grade Chitosan Average Price by Application (2018-2023) & (US$/Kg)
Table 94. Global Medical Grade Chitosan Average Price by Application (2024-2029) & (US$/Kg)
Table 95. North America Medical Grade Chitosan Sales Quantity by Type (2018-2023) & (Ton)
Table 96. North America Medical Grade Chitosan Sales Quantity by Type (2024-2029) & (Ton)
Table 97. North America Medical Grade Chitosan Sales Quantity by Application (2018-2023) & (Ton)
Table 98. North America Medical Grade Chitosan Sales Quantity by Application (2024-2029) & (Ton)
Table 99. North America Medical Grade Chitosan Sales Quantity by Country (2018-2023) & (Ton)
Table 100. North America Medical Grade Chitosan Sales Quantity by Country (2024-2029) & (Ton)
Table 101. North America Medical Grade Chitosan Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Medical Grade Chitosan Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Medical Grade Chitosan Sales Quantity by Type (2018-2023) & (Ton)
Table 104. Europe Medical Grade Chitosan Sales Quantity by Type (2024-2029) & (Ton)
Table 105. Europe Medical Grade Chitosan Sales Quantity by Application (2018-2023) & (Ton)
Table 106. Europe Medical Grade Chitosan Sales Quantity by Application (2024-2029) & (Ton)
Table 107. Europe Medical Grade Chitosan Sales Quantity by Country (2018-2023) & (Ton)
Table 108. Europe Medical Grade Chitosan Sales Quantity by Country (2024-2029) & (Ton)
Table 109. Europe Medical Grade Chitosan Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Medical Grade Chitosan Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Medical Grade Chitosan Sales Quantity by Type (2018-2023) & (Ton)
Table 112. Asia-Pacific Medical Grade Chitosan Sales Quantity by Type (2024-2029) & (Ton)
Table 113. Asia-Pacific Medical Grade Chitosan Sales Quantity by Application (2018-2023) & (Ton)
Table 114. Asia-Pacific Medical Grade Chitosan Sales Quantity by Application (2024-2029) & (Ton)
Table 115. Asia-Pacific Medical Grade Chitosan Sales Quantity by Region (2018-2023) & (Ton)
Table 116. Asia-Pacific Medical Grade Chitosan Sales Quantity by Region (2024-2029) & (Ton)
Table 117. Asia-Pacific Medical Grade Chitosan Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Medical Grade Chitosan Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Medical Grade Chitosan Sales Quantity by Type (2018-2023) & (Ton)
Table 120. South America Medical Grade Chitosan Sales Quantity by Type (2024-2029) & (Ton)
Table 121. South America Medical Grade Chitosan Sales Quantity by Application (2018-2023) & (Ton)
Table 122. South America Medical Grade Chitosan Sales Quantity by Application (2024-2029) & (Ton)
Table 123. South America Medical Grade Chitosan Sales Quantity by Country (2018-2023) & (Ton)
Table 124. South America Medical Grade Chitosan Sales Quantity by Country (2024-2029) & (Ton)
Table 125. South America Medical Grade Chitosan Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Medical Grade Chitosan Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Medical Grade Chitosan Sales Quantity by Type (2018-2023) & (Ton)
Table 128. Middle East & Africa Medical Grade Chitosan Sales Quantity by Type (2024-2029) & (Ton)
Table 129. Middle East & Africa Medical Grade Chitosan Sales Quantity by Application (2018-2023) & (Ton)
Table 130. Middle East & Africa Medical Grade Chitosan Sales Quantity by Application (2024-2029) & (Ton)
Table 131. Middle East & Africa Medical Grade Chitosan Sales Quantity by Region (2018-2023) & (Ton)
Table 132. Middle East & Africa Medical Grade Chitosan Sales Quantity by Region (2024-2029) & (Ton)
Table 133. Middle East & Africa Medical Grade Chitosan Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Medical Grade Chitosan Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Medical Grade Chitosan Raw Material
Table 136. Key Manufacturers of Medical Grade Chitosan Raw Materials
Table 137. Medical Grade Chitosan Typical Distributors
Table 138. Medical Grade Chitosan Typical Customers
List of Figures
Figure 1. Medical Grade Chitosan Picture
Figure 2. Global Medical Grade Chitosan Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Medical Grade Chitosan Consumption Value Market Share by Type in 2022
Figure 4. Animal Origin Chitosan Examples
Figure 5. Plant Based Chitosan Examples
Figure 6. Global Medical Grade Chitosan Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Medical Grade Chitosan Consumption Value Market Share by Application in 2022
Figure 8. Wound Care Examples
Figure 9. Healthcare Products Examples
Figure 10. Antibacterial Products Examples
Figure 11. Others Examples
Figure 12. Global Medical Grade Chitosan Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Medical Grade Chitosan Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Medical Grade Chitosan Sales Quantity (2018-2029) & (Ton)
Figure 15. Global Medical Grade Chitosan Average Price (2018-2029) & (US$/Kg)
Figure 16. Global Medical Grade Chitosan Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Medical Grade Chitosan Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Medical Grade Chitosan by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Medical Grade Chitosan Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Medical Grade Chitosan Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Medical Grade Chitosan Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Medical Grade Chitosan Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Medical Grade Chitosan Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Medical Grade Chitosan Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Medical Grade Chitosan Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Medical Grade Chitosan Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Medical Grade Chitosan Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Medical Grade Chitosan Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Medical Grade Chitosan Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Medical Grade Chitosan Average Price by Type (2018-2029) & (US$/Kg)
Figure 31. Global Medical Grade Chitosan Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Medical Grade Chitosan Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Medical Grade Chitosan Average Price by Application (2018-2029) & (US$/Kg)
Figure 34. North America Medical Grade Chitosan Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Medical Grade Chitosan Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Medical Grade Chitosan Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Medical Grade Chitosan Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Medical Grade Chitosan Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Medical Grade Chitosan Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Medical Grade Chitosan Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Medical Grade Chitosan Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Medical Grade Chitosan Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Medical Grade Chitosan Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Medical Grade Chitosan Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Medical Grade Chitosan Consumption Value Market Share by Region (2018-2029)
Figure 54. China Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Medical Grade Chitosan Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Medical Grade Chitosan Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Medical Grade Chitosan Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Medical Grade Chitosan Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Medical Grade Chitosan Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Medical Grade Chitosan Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Medical Grade Chitosan Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Medical Grade Chitosan Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Medical Grade Chitosan Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Medical Grade Chitosan Market Drivers
Figure 75. Medical Grade Chitosan Market Restraints
Figure 76. Medical Grade Chitosan Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Medical Grade Chitosan in 2022
Figure 79. Manufacturing Process Analysis of Medical Grade Chitosan
Figure 80. Medical Grade Chitosan Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
